Problematic trial detection in ClinicalTrials.gov

Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect pro...

Full description

Bibliographic Details
Main Authors: Chris Hartgerink, Stephen George
Format: Article
Language:English
Published: Pensoft Publishers 2015-12-01
Series:Research Ideas and Outcomes
Subjects:
da
Online Access:https://riojournal.com/article/7462/
id doaj-6d717889465a4949ab1cb1d2e4eb8682
record_format Article
spelling doaj-6d717889465a4949ab1cb1d2e4eb86822020-11-25T01:30:55ZengPensoft PublishersResearch Ideas and Outcomes2367-71632015-12-0111910.3897/rio.1.e74627462Problematic trial detection in ClinicalTrials.govChris Hartgerink0Stephen George1Tilburg UniversityDuke University Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect problematic data. This project aims to develop new methods and apply them to results reported in the ClinicalTrials.gov database. Using both established and and the newly developed statistical methods we will investigate the prevalence of problematic data, trends of problematic data over time, and whether the prevalence of problematic data is predicted by trial characteristics such as funding type. https://riojournal.com/article/7462/clinicaltrials.govproblematic dataerrorda
collection DOAJ
language English
format Article
sources DOAJ
author Chris Hartgerink
Stephen George
spellingShingle Chris Hartgerink
Stephen George
Problematic trial detection in ClinicalTrials.gov
Research Ideas and Outcomes
clinicaltrials.gov
problematic data
error
da
author_facet Chris Hartgerink
Stephen George
author_sort Chris Hartgerink
title Problematic trial detection in ClinicalTrials.gov
title_short Problematic trial detection in ClinicalTrials.gov
title_full Problematic trial detection in ClinicalTrials.gov
title_fullStr Problematic trial detection in ClinicalTrials.gov
title_full_unstemmed Problematic trial detection in ClinicalTrials.gov
title_sort problematic trial detection in clinicaltrials.gov
publisher Pensoft Publishers
series Research Ideas and Outcomes
issn 2367-7163
publishDate 2015-12-01
description Clinical trials are crucial in determining the effectiveness of treatments and directly affect clinical and policy decisions. These decisions are undermined if the data are problematic due to data fabrication or other errors. Researchers have worked on developing statistical methods to detect problematic data. This project aims to develop new methods and apply them to results reported in the ClinicalTrials.gov database. Using both established and and the newly developed statistical methods we will investigate the prevalence of problematic data, trends of problematic data over time, and whether the prevalence of problematic data is predicted by trial characteristics such as funding type.
topic clinicaltrials.gov
problematic data
error
da
url https://riojournal.com/article/7462/
work_keys_str_mv AT chrishartgerink problematictrialdetectioninclinicaltrialsgov
AT stephengeorge problematictrialdetectioninclinicaltrialsgov
_version_ 1725088973974405120